Cite
MLA Citation
Vera Bril et al.. “Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.” Lancet neurology, vol. 22, no. 5, 2023, pp. 383–394. http://access.bl.uk/ark:/81055/vdc_100184057502.0x000019